Primaxin and Lung disorder - a phase IV clinical study of FDA data

Summary:

Lung disorder is reported as a side effect among people who take Primaxin (cilastatin sodium; imipenem), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Pulmonary embolism.

The phase IV clinical study analyzes which people have Lung disorder when taking Primaxin. It is created by eHealthMe based on reports of 4,534 people who have side effects when taking Primaxin from the FDA, and is updated regularly.

What is Primaxin?

Primaxin has active ingredients of cilastatin sodium; imipenem. eHealthMe is studying from 4,540 Primaxin users. Check the latest studies of Primaxin.

What is Lung disorder?

Lung disorder (lung disease) is found to be associated with 1,799 drugs and 1,787 conditions by eHealthMe. Check the latest studies of Lung disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

4,534 people reported to have side effects when taking Primaxin.
Among them, 22 people (0.49%) have Lung disorder.

Among these 22 people:

How long have people been on Primaxin when they have Lung disorder? *

What is the gender of people who have Lung disorder when taking Primaxin? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Lung disorder when taking Primaxin? *

What are other drugs people take besides Primaxin? *

What are other side effects people have besides Lung disorder? *

Pleural Effusion (water on the lungs): 6 people, 27.27%
Cardiac Disorder: 5 people, 22.73%
Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 22.73%
Bradycardia (abnormally slow heart action): 5 people, 22.73%
Arrhythmias (irregular heartbeat): 5 people, 22.73%
Myocarditis (inflammation of heart muscle myocardium): 4 people, 18.18%
Pericardial Effusion (fluid around the heart): 4 people, 18.18%
Hypotension (abnormally low blood pressure): 3 people, 13.64%
Multi-Organ Failure (multisystem organ failure): 3 people, 13.64%
Fever: 3 people, 13.64%

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 18.18%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.09%
Type 2 Diabetes: 1 person, 4.55%
Thrombocytopenia (decrease of platelets in blood): 1 person, 4.55%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 4.55%
Osteitis (a general term for inflammation of bone): 1 person, 4.55%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 1 person, 4.55%
Hypotension (abnormally low blood pressure): 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Primaxin and have Lung disorder?

- Check whether Lung disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Primaxin:

Primaxin (4,540 reports)

Lung disorder treatments and more:

Lung disorder (66,567 reports)

Browse all side effects of Primaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung disorder:

Lung disorder (1,799 drugs)

Browse all the conditions that are associated with Lung disorder:

Lung disorder (1,787 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilastatin sodium; imipenem (the active ingredients of Primaxin) and Primaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.